Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tougeron

Showing results (91-100 of 235) with videos related to

Pageof 24
Sort By:
Biomedicines|May 28, 2022
Safety of FOLFIRI + Durvalumab +/- Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59Camille Evrard, Thomas Aparicio, Emilie Soularue, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL studyLeonard Depotte, Paula Nay, Christophe Borg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2009
Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutationsDavid Tougeron, Emilie Fauquembergue, Alexandre Rouquette, et al.
Journal for Immunotherapy of Cancer|November 5, 2020
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II studyRomain Cohen, Jaafar Bennouna, Aurélia Meurisse, et al.
Neuroendocrinology|February 14, 2019
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score AnalysesLouis de Mestier, Thomas Walter, Hedia Brixi, et al.
Clinical Colorectal Cancer|March 26, 2022
Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"Clélia Coutzac, Isabelle Trouilloud, Pascal Artru, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2019
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter studyAnne-Laure Pointet, David Tougeron, Simon Pernot, et al.
Therapeutic Advances in Gastroenterology|June 23, 2025
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancerPaul Franques, Pierre Moreau, Camille Evrard, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 23, 2023
Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer Highlights Specific Stemness Signature and Shared Molecular FeaturesAmandine Desette, Pierre-Olivier Guichet, Sheik Emambux, et al.
Pageof 24

Showing results (91-100 of 235) with videos related to

Sort By:
Pageof 24
Biomedicines|May 28, 2022
Safety of FOLFIRI + Durvalumab +/- Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59Camille Evrard, Thomas Aparicio, Emilie Soularue, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL studyLeonard Depotte, Paula Nay, Christophe Borg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2009
Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutationsDavid Tougeron, Emilie Fauquembergue, Alexandre Rouquette, et al.
Journal for Immunotherapy of Cancer|November 5, 2020
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II studyRomain Cohen, Jaafar Bennouna, Aurélia Meurisse, et al.
Neuroendocrinology|February 14, 2019
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score AnalysesLouis de Mestier, Thomas Walter, Hedia Brixi, et al.
Clinical Colorectal Cancer|March 26, 2022
Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"Clélia Coutzac, Isabelle Trouilloud, Pascal Artru, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2019
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter studyAnne-Laure Pointet, David Tougeron, Simon Pernot, et al.
Therapeutic Advances in Gastroenterology|June 23, 2025
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancerPaul Franques, Pierre Moreau, Camille Evrard, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 23, 2023
Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer Highlights Specific Stemness Signature and Shared Molecular FeaturesAmandine Desette, Pierre-Olivier Guichet, Sheik Emambux, et al.
Pageof 24